tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Compare Phathom Pharmaceuticals (PHAT) vs. Competitors

Compare
589 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Phathom Pharmaceuticals
$11.21
$883.33M
-5.47
79.07%
6 Buy
1 Hold
0 Sell
Strong Buy
Geron
$1.46
$935.20M
-10.26
-16.57%
3 Buy
1 Hold
1 Sell
Moderate Buy
Arbutus Biopharma
$4.32
$815.45M
-28.12
28.10%
Urogen Pharma
$17.62
$857.78M
-7.34
46.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.40
$1.26B
-16.13
158.82%
9 Buy
0 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$22.30
$1.28B
-4.30
161.74%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAT
Phathom Pharmaceuticals
11.21
4.66
71.15%
GERN
Geron
1.46
-0.29
-16.57%
ABUS
Arbutus Biopharma
4.24
0.85
25.07%
URGN
Urogen Pharma
17.62
5.72
48.07%
TSHA
Taysha Gene Therapies
4.40
2.74
165.06%
ZBIO
Zenas BioPharma, Inc.
22.30
12.99
139.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts